Musculoskeletal medicine: the challenge of the Bone and Joint Decade
- 29 October 2004
- journal article
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 7 (3) , 272-277
- https://doi.org/10.1111/j.1479-8077.2004.00102.x
Abstract
The Bone and Joint Decade (2000–2010) provides a catalyst for the further development of musculoskeletal medicine. The Bone and Joint Decade (BJD) provides an opportunity to bring together industry, governments, health professionals and patients to further research education and services in musculoskeletal diseases.The challenges for musculoskeletal medicine include an ageing population suffering increasingly from chronic multisystem disease, new technologies including pharmaceuticals, biomaterials and prostheses which come at increasing cost, and a health system which is increasingly required to focus on cost‐effectiveness, patient outcomes and patient involvement.All those involved in providing services in the area of musculoskeletal medicine have an opportunity to work together and create new systems of healthcare delivery. This is likely to involve a blurring of the barriers between the specialties and the health professions themselves to create a more sustainable, outcomes‐orientated health delivery system. It may lead to task substitution within the musculoskeletal health professionals, the emergence of new forms of ‘generic’ musculoskeletal health professionals and significant changes in the way we delivery education and research. The new ‘musculoskeletal medicine’ will depend much more on inter‐professional training, multidisciplinary research and team management with a patient outcome focus.Keywords
This publication has 26 references indexed in Scilit:
- Global core recommendations for a musculoskeletal undergraduate curriculumAnnals of the Rheumatic Diseases, 2004
- Cardiovascular effects of selective cyclooxygenase-2 inhibitorsExpert Review of Cardiovascular Therapy, 2004
- Impact of initial aggressive drug treatment with a combination of disease‐modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: A five‐year randomized followup trialArthritis & Rheumatism, 2004
- Stem cell therapy in a caprine model of osteoarthritisArthritis & Rheumatism, 2003
- A view of our future: The case for redesigning rheumatology practiceArthritis Care & Research, 2003
- From best evidence to best practice: effective implementation of change in patients' careThe Lancet, 2003
- Tackling ischaemic heart disease in rheumatoid arthritisRheumatology, 2003
- Hip fracture patients are not treated for osteoporosis: A call to actionArthritis Care & Research, 2002
- Guidelines for the treatment of osteoarthritisAnnals of the Rheumatic Diseases, 2002
- Postmodern medicineThe Lancet, 1999